Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Trace Elem Med Biol ; 56: 6-12, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31442955

RESUMO

OBJECTIVE: The association between plasma selenium and new-onset diabetes in hypertensive adults is still unclear. We aimed to evaluate the relationship of baseline plasma selenium with new-onset diabetes and examine possible effect modifiers in a post-hoc analysis of the China Stroke Primary Prevention Trial (CSPPT). METHODS: A total of 2367 hypertensive, non-diabetic patients with plasma selenium measurements at baseline were included. The primary outcome was new-onset diabetes, defined as physician-diagnosed diabetes or use of glucose-lowering drugs during the follow-up period, or fasting glucose (FG) ≥126.0 mg/dL at the exit visit. RESULTS: At baseline, higher FG levels were found among participants with plasma selenium in quartile 4 (≥94.8 µg/L) (ß, 1.64 mg/dL; 95%CI: 0.54, 2.73) compared to those in quartiles 1-3. During a median follow-up duration of 4.5 years, new-onset diabetes occurred in 270 (11.4%) participants. Graphic plot showed a positive association between baseline selenium levels and risk of new-onset diabetes. This was further confirmed by adjusted regression analyses; the odds ratios (OR) for new-onset diabetes comparing quartile 4 (≥94.8 µg/L) to quartiles 1-3 was 1.36 (95%CI: 1.01, 1.83). No clear trend was evident across quartiles 1-3. CONCLUSIONS: Our data suggest that high plasma selenium (≥94.8 µg/L) was associated with increased risk of new-onset diabetes in hypertensive patients.


Assuntos
Diabetes Mellitus/sangue , Diabetes Mellitus/epidemiologia , Hipertensão/complicações , Selênio/sangue , Adulto , Glicemia/análise , Jejum/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
2.
Zhong Yao Cai ; 32(10): 1602-5, 2009 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-20112727

RESUMO

OBJECTIVE: To optimize the technological parameters of the extraction and purification process of total ginsenosides from Radix Ginseng. METHODS: With the contents of ginsenoside Rg1, ginsenoside Re and ginsenoside Rb1, the orthogonal design was adopted to optimize the extraction process. The purification process was studied by optimizing the elutive ratio of total ginsenosides as the marker. HPLC and spectrophotometer were employed for the study. RESULTS: The optimum conditions were as follows:Using 8 times volume of 75% ethanol extracting for 120 minutes and 2 times, the extraction temperature was 85 degrees C. AB-8 macroporous resin was selected, and the eluant was 4 BV 70% ethanol. CONCLUSION: The optimal conditions of extracting and purifying the total ginsenosides from Radix Ginseng is feasible.


Assuntos
Ginsenosídeos/isolamento & purificação , Panax/química , Plantas Medicinais/química , Resinas Sintéticas/química , Tecnologia Farmacêutica/métodos , Adsorção , Cromatografia Líquida de Alta Pressão , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/isolamento & purificação , Etanol/química , Ginsenosídeos/análise , Raízes de Plantas/química , Reprodutibilidade dos Testes , Solventes , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA